+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pharmaceutical Regulatory Affairs Market Size, Share & Trends Analysis Report By Services, By Category, By Service Provider, By Company Size, By Product Stage, By Indication, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 225 Pages
  • August 2023
  • Region: Global
  • Grand View Research
  • ID: 5876174
Description Jump to:
The global pharmaceutical regulatory affairs market size is expected to reach USD 14.90 billion by 2030. The market is projected to grow at a CAGR of 7.7% from 2023 to 2030. The key factors driving the market growth are the changing regulatory landscape and growth in emerging areas such as personalized medicine, biosimilars, and orphan drugs. There have been significant changes to the FDA’s drug approval processes. Recently, the 21st Century Cures bill was passed, which is expected to speed up the approval process of the FDA for certain types of drugs.

The FDA has launched four programs-Accelerated Approval, Priority Review, Fast Track, and Breakthrough Therapy-to expedite drug reviews for serious and life-threatening diseases. The medicines under these programs are approved faster by regulatory agencies. In addition, in the UK, the launch of The Accelerated Access Collaborative, a government initiative to fast-track patient access to potential breakthrough medicines, is anticipated to boost the availability and accessibility of novel therapies in the country. These changes in approval processes are expected to drive innovation and increase the demand for regulatory service providers who are well-acquainted with recent changes in approval processes globally.

The demand for regulatory specialization in these fields is anticipated to increase with the growth of the markets for biosimilar, orphan medications, personalized medicines, companion diagnostics, adaptive trial designs, and other products. Demand for specialized service providers with expertise in regulatory affairs is increasing as companies expand into different industries and face a growing burden of regulatory compliance. Government financing has considerably accelerated the development of orphan medications, particularly in industrialized economies.

Several companies are involved in collaborations, acquisitions, and new product development to gain a position in the market. For instance, in October 2022, Freyr partnered with an orthopedic implant manufacturing company in Korea, and as per the agreement, provided it with regulatory device registration and legal representation services. Moreover, in January 2022, Parexel International Corporation formed a Regulatory & Access Consulting Organization. This organization was established to provide regulatory support to clinical studies from the early stages.

Pharmaceutical Regulatory Affairs Market Report Highlights

  • In terms of category, the drug segment held the largest revenue share of over 57% in 2022. The growing population, increasing urbanization, and rising demand for quality healthcare in the country have created a significant potential for pharmaceutical companies that develop and manufacture innovative drugs
  • Based on category, the biologics segment is anticipated to register the fastest CAGR of 7.84% over the forecast period owing to the prevalence of diseases such as malaria, HIV/AIDS, and non-communicable diseases
  • In terms of indication, the immunology segment is projected to grow at the fastest CAGR of 9.24% over the forecast period. The robust immunology pipeline of pharmaceutical and biopharmaceutical companies is anticipated to further boost segment growth
  • The oncology segment dominated the market in 2022 with the largest revenue share of 33.08%. This can be attributed to the high prevalence of cancer, which is boosting the need for safe and effective treatment options
  • In terms of product stage, the clinical studies segment held the largest market share of 46.41% in 2022. This can be attributed to the increasing number of clinical trial registrations, which is expected to drive the segment growth
  • The preclinical segment is projected to grow at the fastest CAGR of 8.40% during the forecast period. Increasing prevalence of existing diseases such as cancer, CVDs, & neurological diseases are factors driving the market growth
  • In terms of service providers, the outsourced regulatory affairs segment held the largest market share in 2022 at 56.26% and is anticipated to witness the fastest CAGR of 9.31% over the forecast period. The increasing popularity of these services can be attributed to the fact that outsourcing enables healthcare companies to reduce costs, which is a major contributing factor to market growth
  • In terms of region, Asia Pacific dominated the market in 2022 and held the largest revenue share of 37.46% due to the growing number of clinical trials conducted in the region and the improved regulatory landscape


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Regional scope
1.2 Estimates and Forecast Timeline
1.3 Market Definition
1.4 Research Methodology
1.5 Information Procurement
1.5.1 Information analysis
1.5.2 Market formulation & data visualization
1.5.3 Data validation & publishing
1.6 Research Scope and Assumptions
1.6.1 Commodity Flow Analysis
1.6.2 Top-down market estimation
1.6.3 Region/Country based segment share calculation
1.6.4 Multivariate analysis
1.6.5 Pharmaceutical regulatory affairs Market: CAGR Calculation
1.7 List of Secondary Sources
1.8 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Segment Snapshot
2.4 Segment Snapshot
2.5 Competitive Landscape Snapshot
Chapter 3 Pharmaceutical Regulatory Affairs Market: Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Pharmaceutical Regulatory Affairs Market Dynamics
3.2.1 Market Driver Impact Analysis
3.2.1.1 Changing regulatory landscape
3.2.1.2 Life sciences companies focusing on their core competencies
3.2.1.3 Economic and competitive pressures
3.2.1.4 Demand for the faster approval process for breakthrough drugs and devices
3.2.1.5 Entry of Companies into the global market
3.2.1.6 Growth in emerging areas such as personalized medicine, biosimilars, and orphan drugs
3.2.2 Market Restraint Analysis
3.2.2.1 Risk associated with data security
3.2.2.2 Monitoring issues and lack of standardization
3.2.3 Industry Analysis - Porter’s
3.2.4 PESTEL Analysis
3.3 COVID- 19 Impact and Reformation Strategies
3.3.1 COVID-19 Impact On Clinical Trial Services Market
3.3.2 COVID-19 Impact on Regulatory Services Market
3.3.3 COVID-19 Impact on Key Market Players
3.3.3.1 medpace
3.3.3.2 Icon Plc
3.3.3.3 Labcorp
3.3.3.4 Charles River Laboratories
3.3.4 Post COVID-19 Market Scenario
3.4 Service Gap Analysis
3.4.1 Market Opportunities
3.4.1.1 Service Upgrade
3.4.1.2 Technological Advancements
3.4.1.3 Latest Trends
3.4.2 Market Challenges
3.4.2.1 Analysis Pertaining To Existing Gaps & Shortcomings In The Regulatory Services
3.4.2.2 Bottlenecks Faced By Companies Seeking Regulatory Approvals Or Maintaining Compliance
3.5 Africa's Pharmaceutical Market Composition
3.5.1 Botswana
3.5.2 Namibia
3.5.3 Zimbabwe
3.5.4 Zambia
3.5.5 Tanzania
3.5.6 Rwanda
3.5.7 Ghana
3.5.8 Nigeria
3.5.9 Uganda
3.5.10 Mauritius
3.5.11 Kenya
3.6 Qualitative Analysis of Primary Factors Driving Market Demand for Pharmaceutical Products and Healthcare Services across the Aforementioned African Countries
3.6.1 Market Drivers Analysis
3.6.1.1 Population Growth
3.6.1.2 Increase Disease Burden
3.6.1.3 Rising Government Investments
3.6.2 Market Restraints Analysis
3.6.2.1 Weak Supply Chain Management
3.7 Best Practices and Case Studies Pertaining to Regulatory Affairs Services
Chapter 4 Pharmaceutical Regulatory Affairs Market: Segment Analysis, by Services, 2018 - 2030 (USD Million)
4.1 Pharmaceutical Regulatory Affairs Market: Services Movement Analysis
4.2 Pharmaceutical Regulatory Affairs Market Estimates & Forecast, by Services (USD Million)
4.2.1 Regulatory Consulting
4.2.1.1 Legal Representation
4.2.1.2 Regulatory Writing & Publishing
4.2.1.3.1Writing
4.2.1.4.2Publishing
4.2.1.5 Product Registration & Clinical Trial Applications
4.2.2 Other Services
Chapter 5 Pharmaceutical Regulatory Affairs Market: Segment Analysis, By Category, 2018 - 2030 (USD Million)
5.1 Pharmaceutical Regulatory Affairs Market: Category Movement Analysis
5.2 Pharmaceutical Regulatory Affairs Market Estimates & Forecast, By Category (USD Million)
5.2.1 Drugs
5.2.1.1 Innovator
5.2.1.1.1 Preclinical
5.2.1.1.2 Clinical
5.2.1.1.3Pre-Market Approval (PMA)
5.2.1.2 Generics
5.2.1.2.1 Preclinical
5.2.1.2.2 Clinical
5.2.1.2.3Pre-Market Approval (PMA)
5.2.2 Biologics
5.2.2.1 Biotech
5.2.2.1.1 Preclinical
5.2.2.1.2 Clinical
5.2.2.1.3 Pre-Market Approval (PMA)
5.2.2.2 ATMP
5.2.2.2.1 Preclinical
5.2.2.2.2 Clinical
5.2.2.2.3 Pre-Market Approval (PMA)
5.2.2.3 Biosimilars
5.2.2.3.1 Preclinical
5.2.2.3.2 Clinical
5.2.2.3.3 Pre-Market Approval (PMA)
Chapter 6 Pharmaceutical Regulatory Affairs Market: Segment Analysis, by Indication, 2018 - 2030 (USD Million)
6.1 Pharmaceutical Regulatory Affairs Market: Indication Movement Analysis
6.2 Pharmaceutical Regulatory Affairs Market Estimates & Forecast, by Indication (USD Million)
6.2.1 Oncology
6.2.2 Neurology
6.2.3 Cardiology
6.2.4 Immunology
6.2.5 Others
Chapter 7 Pharmaceutical Regulatory Affairs Market: Segment Analysis, by Product Stage, 2018 - 2030 (USD Million)
7.1 Pharmaceutical Regulatory Affairs Market: Product Stage Movement Analysis
7.2 Pharmaceutical Regulatory Affairs Market Estimates & Forecast, by Product Stage (USD Million)
7.2.1 Preclinical
7.2.2 Clinical studies
7.2.3 PMA
Chapter 8 Pharmaceutical Regulatory Affairs Market: Segment Analysis, by Service Provider, 2018 - 2030 (USD Million)
8.1 Pharmaceutical Regulatory Affairs Market: Service Provider Movement Analysis
8.2 Pharmaceutical Regulatory Affairs Market Estimates & Forecast, by Service (USD Million)
8.2.1 In-house
8.2.2 Outsourcing
Chapter 9 Pharmaceutical Regulatory Affairs Market: Segment Analysis, by Company Size, 2018 - 2030 (USD Million)
9.1 Pharmaceutical Regulatory Affairs Market: Company Size Movement Analysis
9.2 Pharmaceutical Regulatory Affairs Market Estimates & Forecast, by Company Size (USD Million)
9.2.1 Small
9.2.2 Medium
9.2.3 Large
Chapter 10 Pharmaceutical Regulatory Affairs Market: Regional Analysis
10.1 Regulatory Affairs: Regional Market Share Analysis, 2022 & 2030
10.2 North America
10.2.1 North America pharmaceutical regulatory affairs market estimates and Forecasts, 2018 - 2030 (USD Million)
10.2.2 U.S.
10.2.2.1 Key country dynamics
10.2.2.2 Competitive scenario
10.2.2.3 Regulatory framework
10.2.2.4 U.S. pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.2.3 Canada
10.2.3.1 Key country dynamics
10.2.3.2 Competitive scenario
10.2.3.3 Regulatory framework
10.2.3.4 Canada pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.3 Europe
10.3.1 Europe pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.3.2 UK
10.3.2.1 Key country dynamics
10.3.2.2 Competitive scenario
10.3.2.3 Regulatory framework
10.3.2.4 Uk pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.3.3 Germany
10.3.3.1 Key country dynamics
10.3.3.2 Competitive scenario
10.3.3.3 Regulatory framework
10.3.3.4 Germany pharmaceutical regulatory affairs market estimates and Forecasts, 2018 - 2030 (USD Million)
10.3.4 France
10.3.4.1 Key country dynamics
10.3.4.2 Competitive scenario
10.3.4.3 Regulatory framework
10.3.4.4 France pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.3.5 Italy
10.3.5.1 Key country dynamics
10.3.5.2 Competitive scenario
10.3.5.3 Regulatory framework
10.3.5.4 ITALY pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.3.6 Spain
10.3.6.1 Key country dynamics
10.3.6.2 Competitive scenario
10.3.6.3 Regulatory framework
10.3.6.4 SPAIN pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.3.7 Russia
10.3.7.1 Key country dynamics
10.3.7.2 Competitive scenario
10.3.7.3 Regulatory framework
10.3.7.4 russia pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.3.8 Turkey
10.3.8.1 Key country dynamics
10.3.8.2 Competitive scenario
10.3.8.3 Regulatory framework
10.3.8.4 Turkey pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.3.9 Netherland
10.3.9.1 Key country dynamics
10.3.9.2 Competitive scenario
10.3.9.3 Regulatory framework
10.3.9.4 Netherland pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.3.10 Switzerland
10.3.10.1 Key country dynamics
10.3.10.2 Competitive scenario
10.3.10.3 Switzerland pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.3.11 Sweden
10.3.11.1 Key country dynamics
10.3.11.2 Competitive scenario
10.3.11.3 Regulatory framework
10.3.11.4 Sweden pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.4 Asia Pacific
10.4.1 Asia Pacific pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.4.2 Japan
10.4.2.1 Key country dynamics
10.4.2.2 Competitive scenario
10.4.2.3 Regulatory framework
10.4.2.4 Japan pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.4.3 China
10.4.3.1 Key country dynamics
10.4.3.2 Competitive scenario
10.4.3.3 Regulatory framework
10.4.3.4 China pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.4.4 India
10.4.4.1 Key country dynamics
10.4.4.2 Competitive scenario
10.4.4.3 Regulatory framework
10.4.4.4 India pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.4.5 Australia
10.4.5.1 Key country dynamics
10.4.5.2 Competitive scenario
10.4.5.3 Regulatory framework
10.4.5.4 Australia pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.4.6 South Korea
10.4.6.1 Key country dynamics
10.4.6.2 Competitive scenario
10.4.6.3 Regulatory framework
10.4.6.4 South Korea pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.4.7 Indonesia
10.4.7.1 Key country dynamics
10.4.7.2 Competitive scenario
10.4.7.3 Regulatory framework
10.4.7.4 Indonesia pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.4.8 Malaysia
10.4.8.1 Key country dynamics
10.4.8.2 Competitive scenario
10.4.8.3 Regulatory framework
10.4.8.4 Malaysia pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.4.9 Thailand
10.4.9.1 Key country dynamics
10.4.9.2 Competitive scenario
10.4.9.3 Regulatory framework
10.4.9.4 Thailand pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.4.10 Singapore
10.4.10.1 Key country dynamics
10.4.10.2 Competitive scenario
10.4.10.3 Regulatory framework
10.4.10.4 Singapore pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.4.11 Taiwan
10.4.11.1 Key country dynamics
10.4.11.2 Competitive scenario
10.4.11.3 Regulatory framework
10.4.11.4 Taiwan pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.5 Latin America
10.5.1 Latin America pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.5.2 Brazil
10.5.2.1 Key country dynamics
10.5.2.2 Competitive scenario
10.5.2.3 Regulatory framework
10.5.2.4 Brazil pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.5.3 Mexico
10.5.3.1 Key country dynamics
10.5.3.2 Competitive scenario
10.5.3.3 Regulatory framework
10.5.3.4 Mexico pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.5.4 Argentina
10.5.4.1 Key country dynamics
10.5.4.2 Competitive scenario
10.5.4.3 Regulatory framework
10.5.4.4 Argentina pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.5.5 Colombia
10.5.5.1 Key country dynamics
10.5.5.2 Competitive scenario
10.5.5.3 Regulatory framework
10.5.5.4 Colombia pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.5.6 Chile
10.5.6.1 Key country dynamics
10.5.6.2 Competitive scenario
10.5.6.3 Regulatory framework
10.5.6.4 Chile pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.6 Middle East
10.6.1 Middle East pharmaceutical regulatory affairs market estimates and Forecasts, 2018 - 2030 (USD Million)
10.6.2 Saudi Arabia
10.6.2.1 Key country dynamics
10.6.2.2 Competitive scenario
10.6.2.3 Regulatory framework
10.6.2.4 Saudi Arabia pharmaceutical regulatory affairs market estimates and Forecasts, 2018 - 2030 (USD Million)
10.6.3 United Arab Emirates (UAE)
10.6.3.1 Key country dynamics
10.6.3.2 Competitive scenario
10.6.3.3 Regulatory framework
10.6.3.4 UAE pharmaceutical regulatory affairs market estimates and Forecasts, 2018 - 2030 (USD Million)
10.6.4 Egypt
10.6.4.1 Key country dynamics
10.6.4.2 Competitive scenario
10.6.4.3 Regulatory framework
10.6.4.4 Egypt pharmaceutical regulatory affairs market estimates and Forecasts, 2018 - 2030 (USD Million)
10.6.5 Israel
10.6.5.1 Key country dynamics
10.6.5.2 Competitive scenario
10.6.5.3 Regulatory framework
10.6.5.4 Israel pharmaceutical regulatory affairs market estimates and Forecasts, 2018 - 2030 (USD Million)
10.7 Africa
10.7.1 Africa pharmaceutical regulatory affairs market estimates and Forecasts, 2018 - 2030 (USD Million)
10.7.1.1 Competitive scenario
10.7.2 Botswana
10.7.2.1 Key country dynamics
10.7.2.2 Competitive scenario
10.7.2.3 Regulatory framework
10.7.2.4 Botswana pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.7.3 Namibia
10.7.3.1 Key country dynamics
10.7.3.2 Regulatory framework
10.7.3.3 Competitive scenario
10.7.3.4 Namibia pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.7.4 Zimbabwe
10.7.4.1 Key country dynamics
10.7.4.2 Key country dynamics
10.7.4.3 Competitive scenario
10.7.4.4 Regulatory framework
10.7.4.5 Zimbabwe pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.7.5 Zambia
10.7.5.1 Key country dynamics
10.7.5.2 Competitive scenario
10.7.5.3 Regulatory framework
10.7.5.4 pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.7.6 Tanzania
10.7.6.1 Key country dynamics
10.7.6.2 Competitive scenario
10.7.6.3 Regulatory framework
10.7.6.4 Tanzania pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.7.7 Rwanda
10.7.7.1 Key country dynamics
10.7.7.2 Competitive scenario
10.7.7.3 Regulatory framework
10.7.7.4 Rwanda pharmaceutical regulatory affairs market estimates and Forecasts, 2018 - 2030 (USD Million)
10.7.8 Ghana
10.7.8.1 Key country dynamics
10.7.8.2 Competitive scenario
10.7.8.3 Regulatory framework
10.7.8.4 Ghana pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.7.9 Nigeria
10.7.9.1 Key country dynamics
10.7.9.2 Competitive scenario
10.7.9.3 Regulatory framework
10.7.9.4 Nigeria pharmaceutical regulatory affairs market estimates and Forecasts, 2018 - 2030 (USD Million)
10.7.10 Uganda
10.7.10.1 Key country dynamics
10.7.10.2 Competitive scenario
10.7.10.3 Regulatory framework
10.7.10.4 Uganda pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.7.11 Mauritius
10.7.11.1 Key country dynamics
10.7.11.2 Competitive scenario
10.7.11.3 Regulatory framework
10.7.11.4 Mauritius pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
10.7.12 Kenya
10.7.12.1 Key country dynamics
10.7.12.2 Competitive scenario
10.7.12.3 Regulatory framework
10.7.12.4 Kenya pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 11 Pharmaceutical Regulatory Affairs Market: Competitive Landscape
11.1 Company Categorization
11.2 Participants’ Overview
11.3 Financial Performance
11.4 Service Benchmarking
11.4.1 Strategy Mapping
11.4.2 Acquisition
11.4.3 Expansion
11.4.4 Partnership
11.4.5 Others
11.4.6 Company Share Analysis
11.5 Additional list of 20 players operating in the Pharmaceutical Regulatory Affairs Market
11.5.1 SWOT Analysis
11.5.2 Heat Map Analysis
11.5.3 Service Benchmarking
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. List of Secondary Sources
Table 4. List of Abbreviations
Table 5. List of Secondary Sources
Table 6. List of Abbreviations
Table 7. Global Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 8. Global Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 9. Global Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 10. Global Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 11. Global Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 12. Global Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 13. Global Pharmaceutical Regulatory Affairs Market by Region, 2018 - 2030 (USD Million)
Table 14. North America Pharmaceutical Regulatory Affairs Market by Country, 2018 - 2030 (USD Million)
Table 15. North America Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 16. North America Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 17. North America Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 18. North America Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 19. North America Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 20. North America Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 21. U.S. Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 22. U.S. Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 23. U.S. Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 24. U.S. Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 25. U.S. Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 26. U.S. Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 27. Canada Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 28. Canada Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 29. Canada Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 30. Canada Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 31. Canada Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 32. Canada Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 33. Europe Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 34. Europe Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 35. Europe Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 36. Europe Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 37. Europe Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 38. Europe Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 39. Europe Pharmaceutical Regulatory Affairs Market by Country, 2018 - 2030 (USD Million)
Table 40. Germany Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 41. Germany Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 42. Germany Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 43. Germany Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 44. Germany Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 45. Germany Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 46. UK Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 47. UK Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 48. UK Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 49. UK Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 50. UK Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 51. UK Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 52. France Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 53. France Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 54. France Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 55. France Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 56. France Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 57. France Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 58. Italy Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 59. Italy Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 60. Italy Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 61. Italy Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 62. Italy Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 63. Italy Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 64. Spain Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 65. Spain Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 66. Spain Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 67. Spain Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 68. Spain Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 69. Spain Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 70. Russia Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 71. Russia Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 72. Russia Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 73. Russia Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 74. Russia Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 75. Russia Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 76. Turkey Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 77. Turkey Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 78. Turkey Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 79. Turkey Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 80. Turkey Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 81. Turkey Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 82. Netherlands Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 83. Netherlands Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 84. Netherlands Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 85. Netherlands Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 86. Netherlands Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 87. Netherlands Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 88. Switzerland Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 89. Switzerland Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 90. Switzerland Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 91. Switzerland Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 92. Switzerland Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 93. Switzerland Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 94. Sweden Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 95. Sweden Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 96. Sweden Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 97. Sweden Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 98. Sweden Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 99. Sweden Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 100. Asia Pacific Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 101. Asia Pacific Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 102. Asia Pacific Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 103. Asia Pacific Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 104. Asia Pacific Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 105. Asia Pacific Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 106. Asia Pacific Pharmaceutical Regulatory Affairs Market by Country, 2018 - 2030 (USD Million)
Table 107. Asia Pacific Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 108. China Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 109. China Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 110. China Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 111. China Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 112. China Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 113. Japan Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 114. Japan Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 115. Japan Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 116. Japan Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 117. Japan Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 118. Japan Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 119. India Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 120. India Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 121. India Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 122. India Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 123. India Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 124. India Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 125. South Korea Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 126. South Korea Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 127. South Korea Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 128. South Korea Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 129. South Korea Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 130. South Korea Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 131. Australia Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 132. Australia Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 133. Australia Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 134. Australia Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 135. Australia Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 136. Australia Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 137. Thailand Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 138. Thailand Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 139. Thailand Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 140. Thailand Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 141. Thailand Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 142. Thailand Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 143. South Korea Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 144. South Korea Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 145. South Korea Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 146. South Korea Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 147. South Korea Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 148. South Korea Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 149. Indonesia Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 150. Indonesia Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 151. Indonesia Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 152. Indonesia Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 153. Indonesia Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 154. Indonesia Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 155. Malaysia Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 156. Malaysia Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 157. Malaysia Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 158. Malaysia Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 159. Malaysia Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 160. Malaysia Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 161. Singapore Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 162. Singapore Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 163. Singapore Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 164. Singapore Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 165. Singapore Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 166. Singapore Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 167. Taiwan Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 168. Taiwan Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 169. Taiwan Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 170. Taiwan Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 171. Taiwan Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 172. Taiwan Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 173. Latin America Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 174. Latin America Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 175. Latin America Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 176. Latin America Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 177. Latin America Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 178. Latin America Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 179. Latin America Pharmaceutical Regulatory Affairs Market by Country, 2018 - 2030 (USD Million)
Table 180. Brazil Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 181. Brazil Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 182. Brazil Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 183. Brazil Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 184. Brazil Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 185. Brazil Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 186. Mexico Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 187. Mexico Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 188. Mexico Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 189. Mexico Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 190. Mexico Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 191. Mexico Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 192. Argentina Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 193. Argentina Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 194. Argentina Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 195. Argentina Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 196. Argentina Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 197. Argentina Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 198. Colombia Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 199. Colombia Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 200. Colombia Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 201. Colombia Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 202. Colombia Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 203. Colombia Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 204. Chile Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 205. Chile Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 206. Chile Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 207. Chile Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 208. Chile Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 209. Chile Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 210. Middle East Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 211. Middle East Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 212. Middle East Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 213. Middle East Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 214. Middle East Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 215. Middle East Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 216. Middle East Pharmaceutical Regulatory Affairs Market by Country, 2018 - 2030 (USD Million)
Table 217. Saudi Arabia Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 218. Saudi Arabia Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 219. Saudi Arabia Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 220. Saudi Arabia Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 221. Saudi Arabia Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 222. Saudi Arabia Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 223. Egypt Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 224. Egypt Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 225. Egypt Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 226. Egypt Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 227. Egypt Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 228. Egypt Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 229. UAE Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 230. UAE Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 231. UAE Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 232. UAE Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 233. UAE Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 234. UAE Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 235. Israel Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 236. Israel Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 237. Israel Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 238. Israel Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 239. Israel Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 240. Israel Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 241. Africa Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 242. Africa Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 243. Africa Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 244. Africa Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 245. Africa Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 246. Africa Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 247. Africa Pharmaceutical Regulatory Affairs Market by Country, 2018 - 2030 (USD Million)
Table 248. Botswana Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 249. Botswana Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 250. Botswana Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 251. Botswana Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 252. Botswana Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 253. Botswana Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 254. Namibia Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 255. Namibia Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 256. Namibia Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 257. Namibia Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 258. Namibia Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 259. Namibia Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 260. Zimbabwe Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 261. Zimbabwe Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 262. Zimbabwe Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 263. Zimbabwe Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 264. Zimbabwe Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 265. Zimbabwe Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 266. Zambia Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 267. Zambia Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 268. Zambia Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 269. Zambia Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 270. Zambia Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 271. Zambia Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 272. Tanzania Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 273. Tanzania Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 274. Tanzania Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 275. Tanzania Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 276. Tanzania Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 277. Tanzania Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 278. Rwanda Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 279. Rwanda Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 280. Rwanda Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 281. Rwanda Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 282. Rwanda Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 283. Rwanda Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 284. Ghana Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 285. Ghana Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 286. Ghana Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 287. Ghana Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 288. Ghana Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 289. Ghana Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 290. Nigeria Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 291. Nigeria Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 292. Nigeria Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 293. Nigeria Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 294. Nigeria Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 295. Nigeria Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 296. Uganda Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 297. Uganda Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 298. Uganda Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 299. Uganda Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 300. Uganda Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 301. Uganda Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 302. Mauritius Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 303. Mauritius Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 304. Mauritius Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 305. Mauritius Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 306. Mauritius Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 307. Mauritius Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 308. Kenya Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 309. Kenya Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 310. Kenya Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 311. Kenya Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 312. Kenya Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 313. Kenya Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Pharmaceutical regulatory affairs market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Data Analysis Models
Fig. 5 Market Formulation And Validation
Fig. 6 Data Validating & Publishing
Fig. 7 Commodity flow analysis
Fig. 8 Parent market outlook, 2022 (USD Million)
Fig. 9 Ancillary market outlook, 2022 (USD Million)
Fig. 10 Pharmaceutical regulatory affairs market dynamics
Fig. 11 Percentage of products in Japan that received a price change in April 2023.
Fig. 12 Percentage of clinical trial registered in different regions (November 2022)
Fig. 13 Personalized medicine accounted for over 25% of the FDA approval for each of the last 7 years
Fig. 14 Porter’s five forces analysis
Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 16 Usage/adoption of cloud technology for regulatory space
Fig. 17 Africa's Pharmaceutical Market Composition
Fig. 18 Distribution of the 2019 national health budget
Fig. 19 Health budget in USD Million
Fig. 20 Nigeria's imports: medicinal and pharmaceutical products from 1995 to 2021
Fig. 21 Uganda imports of pharmaceutical products
Fig. 22 Pharmaceutical regulatory affairs market: Services outlook and key takeaways
Fig. 23 Pharmaceutical regulatory affairs market: Services movement analysis
Fig. 24 Regulatory consulting market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Legal representation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Regulatory Writing & Publishing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Writing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Publishing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Product registration & clinical trial applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Other services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Pharmaceutical regulatory affairs market: Category outlook and key takeaways
Fig. 32 Pharmaceutical regulatory affairs market: Category movement analysis
Fig. 33 Drugs market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Innovator market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Preclinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Pre - Market Approval (PMA) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Generics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Preclinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Pre - Market Approval (PMA) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Biologics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Biotech market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Preclinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Pre - Market Approval (PMA) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 ATMP market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Preclinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Pre - Market Approval (PMA) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Biosimilars market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Preclinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Pre - Market Approval (PMA) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Pharmaceutical regulatory affairs market: Indication outlook and key takeaways
Fig. 56 Pharmaceutical regulatory affairs market: Indication movement analysis
Fig. 57 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Immunology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Pharmaceutical regulatory affairs market: Product outlook and key takeaways
Fig. 63 Pharmaceutical regulatory affairs market: Product movement analysis
Fig. 64 Preclinical market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Clinical studies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 PMA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Pharmaceutical regulatory affairs market: Service provider outlook and key takeaways
Fig. 68 Pharmaceutical regulatory affairs market: Service provider movement analysis
Fig. 69 In - house market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Outsourcing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 Pharmaceutical regulatory affairs market: Company size outlook and key takeaways
Fig. 72 Pharmaceutical regulatory affairs market: Company size movement analysis
Fig. 73 Small market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Medium market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Large market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Regional market: Key takeaways
Fig. 77 Regional outlook, 2022 & 2030
Fig. 78 North America pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 U.S. pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Canada pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Europe pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 UK pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 Germany pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Key country dynamics
Fig. 89 France pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Key country dynamics
Fig. 91 Italy pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 Spain pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 Russia pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 Key country dynamics
Fig. 97 Turkey pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Key country dynamics
Fig. 99 Netherland pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 100 Key country dynamics
Fig. 101 Switzerland pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 102 Key country dynamics
Fig. 103 Sweden pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 104 Asia Pacific pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 105 Key country dynamics
Fig. 106 Japan pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 107 Key country dynamics
Fig. 108 China pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 109 Key country dynamics
Fig. 110 India pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 111 Key country dynamics
Fig. 112 Australia pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 113 Key country dynamics
Fig. 114 South Korea pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 115 Key country dynamics
Fig. 116 Indonesia pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 117 Key country dynamics
Fig. 118 Malaysia pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 119 Key country dynamics
Fig. 120 Thailand pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 121 Key country dynamics
Fig. 122 Singapore pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 123 Key country dynamics
Fig. 124 Taiwan pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 125 Latin America pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 126 Key country dynamics
Fig. 127 Brazil pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 128 Key country dynamics
Fig. 129 Mexico pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 130 Key country dynamics
Fig. 131 Argentina pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 132 Key country dynamics
Fig. 133 Colombia pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 134 Key country dynamics
Fig. 135 Chile pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 136 Middle East pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 137 Key country dynamics
Fig. 138 Saudi Arabia pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 139 Key country dynamics
Fig. 140 UAE pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 141 Key country dynamics
Fig. 142 Egypt pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 143 Key country dynamics
Fig. 144 Israel pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 145 Africa pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 146 Key country dynamics
Fig. 147 Botswana pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 148 Key country dynamics
Fig. 149 Namibia pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 150 Key country dynamics
Fig. 151 Key country dynamics
Fig. 152 Zimbabwe pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 153 U.S. pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 154 Key country dynamics
Fig. 155 Tanzania pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 156 Key country dynamics
Fig. 157 Rwanda pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 158 Key country dynamics
Fig. 159 Ghana pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 160 Key country dynamics
Fig. 161 Nigeria pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 162 Key country dynamics
Fig. 163 Uganda pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 164 Key country dynamics
Fig. 165 Mauritius pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 166 Key country dynamics
Fig. 167 Kenya pharmaceutical regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 168 Key company categorization
Fig. 169 Company market position analysis
Fig. 170 Strategic framework
Fig. 171 Pharmaceutical regulatory affairs market share analysis, 2022
Fig. 172 SWOT analysis
Fig. 173 Company market position analysis

Companies Mentioned

  • Freyr
  • IQVIA Inc
  • ICON plc
  • WuXi AppTec
  • Charles River Laboratories
  • Labcorp Drug Development
  • Parexel International Corporation
  • Pharmalex GmbH
  • Pharmexon
  • Genpact

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages225
PublishedAugust 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 8.27 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.9 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Pharmaceutical Regulatory Affairs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031 - Product Image

Global Pharmaceutical Regulatory Affairs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • Report
  • 110 Pages
  • Global
From
Nonclinical Safety Assessment. A Guide to International Pharmaceutical Regulations. Edition No. 1 - Product Image

Nonclinical Safety Assessment. A Guide to International Pharmaceutical Regulations. Edition No. 1

  • Book
  • 488 Pages
  • Global
FDA Regulatory Compliance for Drug and Biotech Product - Past, Present and Future (Recorded) - Product Image

FDA Regulatory Compliance for Drug and Biotech Product - Past, Present and Future (Recorded)

  • Training
  • 2 Days
  • Global
From
FDA Regulatory Compliance for Drug and Biotech Product Training Course (Recorded) - Product Image

FDA Regulatory Compliance for Drug and Biotech Product Training Course (Recorded)

  • Training
  • 2 Days
  • Global
Dermatology CRO Market Size, Share & Trends Analysis Report By Type (Preclinical, Clinical), By Service Type (Laboratory, Regulatory/Medical Affairs), By Region (North America, Asia Pacific), And Segment Forecasts, 2023-2030 - Product Image

Dermatology CRO Market Size, Share & Trends Analysis Report By Type (Preclinical, Clinical), By Service Type (Laboratory, Regulatory/Medical Affairs), By Region (North America, Asia Pacific), And Segment Forecasts, 2023-2030

  • Report
  • 175 Pages
  • Global
From

About the Pharmaceutical Regulation Market

The Pharmaceutical Regulation market is a sector of the pharmaceutical industry that focuses on the regulation of drugs and other related products. It is responsible for ensuring that drugs are safe and effective for use by the public. This includes the evaluation of clinical trials, the approval of new drugs, and the monitoring of drug safety and efficacy. The market also includes the enforcement of regulations and the enforcement of intellectual property rights. The Pharmaceutical Regulation market is composed of a variety of stakeholders, including pharmaceutical companies, regulatory authorities, and research institutions. Pharmaceutical companies are responsible for the development and production of drugs, while regulatory authorities are responsible for the approval and monitoring of drugs. Research institutions are responsible for conducting clinical trials and providing data to regulatory authorities. Some of the major companies in the Pharmaceutical Regulation market include Pfizer, Merck, GlaxoSmithKline, Novartis, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.